Feb 02, 2023 / 04:30PM GMT
James Martin - Cocrystal Pharma, Inc. - Interim Co-CEO and CFO
Hello, everyone. I'd like to thank all of you for your interest in Cocrystal. I'd like to thank Sequire for having us here. I'll get started on our presentation.
So Cocrystal, about us. We are a therapeutic company distinguished from a vaccine company in that we cure the disease once a person has it, where vaccines are, in general, more preventative. We have drug candidates which have a clinically validated mechanism of action to cure these diseases. In addition, our program derives itself from a proprietary drug discovery platform, which is based on Nobel-Prize-winning technology, and this technology was industrialized to create Cocrystal.
Some of the investment highlights at Cocrystal include that we target large multi-billion-dollar global markets for both acute and pandemic diseases. As I mentioned, all of our virus antivirals come from our proprietary drug discovery platform. In addition, we have several programs. But the ones highlighted here are our oral influenza, which is a PB2 inhibitor.
We just completed
Cocrystal Pharma Inc at SRAX Sequire Biotechnology Conference (Virtual) Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot